Overview
Growth buyout investor focused on technology-enabled pharmaceutical services, including outsourced complex biomanufacturing, clinical trial services and digital transformation.
Unlock the full profileGet the complete company dossier
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.